Current treatment is aimed at easing the symptoms, reducing inflammation, and controlling the immune system. Anti-TNF therapy, such as infliximab, has shown promise in treating the uveitis associated with the<unk> . Another Anti-TNF agent, etanercept, may be useful in patients with mainly skin and mucosal symptoms. Interferon alfa-2a, azathioprine, colchicine, thalidomide, dapsone and rebamipide are among other agents that are used alternatives.
Behçet's disease medical therapy
Sjögren's syndrome medical therapy
Impetigo medical therapy
Conjunctivitis medical therapy
Erysipelas medical therapy
Behçet's disease classification
Acne vulgaris medical therapy
Scleroderma medical therapy